CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-07 | Lane Michael Executive Vice President | Option exercise | +462 | $67.85 | $31K | 4,507.99 |
| 2023-11-07 | Lane Michael Executive Vice President | Option exercise | +706 | $141.60 | $100K | 5,213.99 |
| 2023-11-07 | Lane Michael Executive Vice President | Option exercise | +560 | $178.26 | $100K | 5,773.99 |
| 2023-11-07 | Lane Michael Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −462 | 0 | ||
| 2023-11-07 | Lane Michael Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2023-11-07 | Lane Michael Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2023-10-30 | JUNIUS DANIEL M Director | Grant or award | +19 | $396.39 | $8K | 3,028 |
| 2023-09-06 | AYERS JONATHAN W Director | Gift | −147,821 | 302,179 | ||
| 2023-09-06 | AYERS JONATHAN W Director | Gift | +147,821 | 281,868 | ||
| 2023-09-01 | Smith Martin Alexander Executive Vice President | Option exercise | +19 | 225.7 | ||
| 2023-09-01 | Smith Martin Alexander Executive Vice President | Shares withheld for taxes | −5 | $511.29 | $3K | 220.7 |
| 2023-09-01 | Smith Martin Alexander Executive Vice President | Option exercise · Restricted Stock Unit | −19 | 1,827 | ||
| 2023-09-01 | Britt Irene Chang Director | Grant or award · Restricted Stock Unit | +208 | 208 | ||
| 2023-09-01 | Britt Irene Chang Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +493 | 493 | ||
| 2023-09-01 | AYERS JONATHAN W Director | Gift | −250 | 134,047 | ||
| 2023-08-31 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +13,424 | $79.54 | $1.1M | 86,349.35 |
| 2023-08-31 | MAZELSKY JONATHAN JAY President and CEO | Sale | −13,424 | $512.01 | $6.9M | 72,925.35 |
| 2023-08-31 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Non-Qualified Stock Option (right-to-buy) | −13,424 | 13,424 | ||
| 2023-08-31 | AYERS JONATHAN W Director | Gift | −1,250 | 134,297 | ||
| 2023-08-29 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +2,627 | $68.75 | $181K | 18,664.99 |
Page 39 of 52 · 1,036 trades